Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 2 |
| Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deal Details | 11 | 27 |
| Asset Purchase | 11 | 1 |
| Proximagen Acquires Two CNS Drug Development Programmes From GlaxoSmithKline | 11 | 2 |
| Partnerships | 13 | 1 |
| Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company | 13 | 1 |
| Proximagen Enters into Co-Development Agreement with Saniona | 14 | 1 |
| MRC Technology Enters into Co-Development Agreement with Proximagen | 15 | 1 |
| Upsher-Smith Labs Enters Into Development Agreement With Lundbeck | 16 | 1 |
| Proximagen And Altacor Enter Into R&D Agreement For Treatment Of Glaucoma | 17 | 2 |
| H. Lundbeck Enters Into Co-Development Agreement With Proximagen | 19 | 1 |
| Novo Nordisk Enters Into Co-Marketing Agreement With Upsher-Smith Labs | 20 | 1 |
| Proximagen Neuroscience Enters Into A Collaboration With The National Institutes of Health | 21 | 2 |
| Licensing Agreements | 23 | 1 |
| F. Hoffmann-La Roche Entered into Licensing Agreement with Proximagen | 23 | 1 |
| Ligand Pharma Enters Into Licensing Agreement With Proximagen Group | 24 | 1 |
| Proximagen Group Enters Into Licensing Agreement With BrainCells | 25 | 2 |
| Upsher-Smith Labs Enters Into Licensing Agreement With Ikano Therapeutics | 27 | 1 |
| Upsher-Smith Labs Enters Into Licensing Agreement With Proximagen | 28 | 2 |
| Asset Transactions | 30 | 1 |
| Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs | 30 | 2 |
| Acquisition | 32 | 1 |
| Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million | 32 | 3 |
| Upsher-Smith Labs Acquires Additional 1.22% Stake In Proximagen | 35 | 1 |
| Proximagen Neuroscience Acquires Minster Pharma | 36 | 2 |
| Upsher-Smith Laboratories, Inc. - Key Competitors | 38 | 1 |
| Key Employees | 39 | 1 |
| Locations And Subsidiaries | 40 | 2 |
| Head Office | 40 | 1 |
| Other Locations &Subsidiaries | 40 | 2 |
| Appendix | 42 | 1 |
| Methodology | 42 | 1 |
| About GlobalData | 42 | 1 |
| Contact Us | 42 | 1 |
| Disclaimer | 42 | 1 |